Draft Conflict-Of-Interest Policy Affects Status Of Many FDA Cmte. Members
This article was originally published in The Gray Sheet
Executive Summary
A "significant fraction" of current FDA advisory committee members' eligibility to vote and/or participate in meetings would be curtailed by a revised conflict-of-interest policy, FDA said